Jasper Therapeutics Inc [NASDAQ: JSPR] loss -55.10% on the last trading session, reaching $3.04 price per share at the time.
Jasper Therapeutics Inc represents 15.02 million in outstanding shares, while the company has a total market value of $45.67 million with the latest information. JSPR stock price has been found in the range of $2.265 to $3.7499.
If compared to the average trading volume of 252.19K shares, JSPR reached a trading volume of 13079118 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Jasper Therapeutics Inc [JSPR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for JSPR shares is $36.12 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on JSPR stock is a recommendation set at 1.55. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Jasper Therapeutics Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on July 07, 2025. The new note on the price target was released on July 07, 2025, representing the official price target for Jasper Therapeutics Inc stock. Previously, the target price had yet another raise to $38, while UBS analysts kept a Buy rating on JSPR stock.
The Price to Book ratio for the last quarter was 1.08, with the Price to Cash per share for the same quarter was set at 3.25.
Trading performance analysis for JSPR stock
Jasper Therapeutics Inc [JSPR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -44.63. With this latest performance, JSPR shares dropped by -49.33% in over the last four-week period, additionally sinking by -85.78% over the last 6 months – not to mention a drop of -85.78% in the past year of trading.
Jasper Therapeutics Inc [JSPR]: A deeper dive into fundamental analysis
Return on Equity for this stock declined to -85.84%, with Return on Assets sitting at -85.84%.
Jasper Therapeutics Inc [JSPR]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for JSPR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Jasper Therapeutics Inc go to 1.30%.
An analysis of Institutional ownership at Jasper Therapeutics Inc [JSPR]
There are presently around $87.94%, or 89.07% of JSPR stock, in the hands of institutional investors. The top three institutional holders of JSPR stocks are: VELAN CAPITAL INVESTMENT MANAGEMENT LP with ownership of 1.47 million shares, which is approximately 9.8216%. SOLEUS CAPITAL MANAGEMENT, L.P., holding 1.28 million shares of the stock with an approximate value of $$28.97 million in JSPR stocks shares; and SOLEUS CAPITAL MANAGEMENT, L.P., currently with $$24.2 million in JSPR stock with ownership which is approximately 7.1144%.
